Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transmyocardial revascularization: defining its role.

Ross F Goldberg1, Arthur E Fass, William H Frishman

  • 1Department of Surgery, St. Vincent's Medical Center, New York, NY, USA.

Cardiology in Review
|December 15, 2004
PubMed
Summary

Transmyocardial revascularization (TMR) uses lasers to create heart channels for angina. Current studies show mixed results, with undefined mechanisms and risks, necessitating further research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The surgeon advocate's role in shaping state and federal policy.

Surgery·2026
Same author

Pressure Recovery in Aortic Stenosis.

Cardiology in review·2025
Same author

Greater Familiarity Between Surgeon and Operating Room-Allied Health Staff Is Associated With Shorter Case Duration-A Multi-institutional Study.

Annals of surgery·2025
Same author

"Policy and Funding Impact on Access to Care".

The American surgeon·2025
Same author

FlowTriever System for Pulmonary Embolism: A Review of Clinical Evidence.

Cardiology in review·2023
Same author

Botulinum Toxin: A Potential Cardiovascular Agent?

Cardiology in review·2023

Area of Science:

  • Cardiovascular Surgery
  • Medical Technology
  • Laser Applications in Medicine

Background:

  • Transmyocardial revascularization (TMR) evolved from low-powered to high-powered lasers for creating cardiac channels.
  • Initial clinical studies focused on patients with inoperable coronary artery disease and refractory angina pectoris.
  • The Food and Drug Administration approved TMR as a standalone therapy based on early findings.

Purpose of the Study:

  • To review the current status of transmyocardial revascularization (TMR) in treating coronary artery disease.
  • To evaluate the efficacy and safety of TMR, particularly when combined with coronary artery bypass surgery.
  • To highlight the need for further investigation into TMR's mechanism of action and clinical benefit.

Main Methods:

Related Experiment Videos

  • Review of clinical studies and Food and Drug Administration approvals related to TMR.
  • Analysis of the evolution of laser technology used in TMR procedures.
  • Examination of contrasting findings from clinical trials regarding TMR efficacy.

    • Main Results:

    • High-powered lasers enable transmyocardial channel creation with minimal tissue damage.
    • TMR has been used as a sole therapy and in combination with coronary artery bypass surgery.
    • Clinical trials report conflicting results on TMR's benefits and associated risks.

    Conclusions:

    • The mechanism of action for transmyocardial revascularization (TMR) remains unclear.
    • The procedure carries potential risks of morbidity and mortality.
    • Further research is required to determine if TMR is a beneficial treatment or a placebo therapy for angina pectoris.